Ilesol Pharmaceuticals is an industrial scale producer of full-spectrum CBD and non-detectable THC products. The company was founded in 2017 by two experts in pharmaceutical process engineering and optimization, medicinal plant extraction methods, active compounds isolation, hemp processing, cultivation, breeding, and optimization.
In the first year, we provided hemp processing and extraction services. We launched our first products in early 2018. From the start, we have been committed to providing our clients with specifically formulated products. This business model made us the first European cannabinoid à la carte company.
Our core business is B2B CBD wholesale and white label CBD services. We offer a wide range of CBD/CBG products, intermediates, cosmetic ingredients, and consumer products. We provide high purity isolated cannabinoids, THC-free, and full-spectrum CBD products of any potency.
In 2019, we acquired a new 3.400 m2 production facility in Varaždin, Croatia. In 2021, we launched our first CBD cosmetics line, Skin Greens — a product collection for healthy and natural skin nutrition based on CBD and high-quality natural herbal active ingredients in functional pharmaceutical formulations.
We can proudly claim to be one of the best cannabis manufacturers in the EU, one of the very few companies with in-house production from Croatian-sourced organic biomass to isolates and finished products. Our quality management system includes Good Manufacturing Practice (GMP) for food production and GMP for cosmetic production, which clearly places us at the top of EU CBD manufacturers.
Full Traceability and Guarantee of raw material origin
Knowledge of cutting-edge extraction and purification technologies
Production according to the highest industrial standards
Analytical support from 3rd party accredited laboratory with accredited analytical methods
Our products undergo rigorous quality control measures to ensure safety, stability, and efficacy.
Our products contain a full spectrum of naturally occurring cannabinoids and terpenes
We are among the strongest candidates for Novel Food approval in the UK, and we are in the process of applying for our Novel Food registration in the EU.
We are compliant with international food safety regulations, meeting the requirements of the United Nations’ Codex Alimentarius Commission (CAC) and the Health Products Regulatory Authority (HPRA). We have implemented the Hazard Analysis Critical Control Points (HACCP) management system; HRN EN ISO 22000:2018 Food Safety Management system and GMP for food production. We hold cosmetic GMP ISO 22716 and ISO 9001 certificates. Our Quality Assurance (QA) and Quality Control (QC) processes assure vigorous implementation of certified Good Manufacturing Practices for food and cosmetic production. All of our products are third-party tested and free of pesticides, toxic solvent residues, and heavy metals. None of our products or ingredients have been tested on animals.
When it comes to our business model, quality is our highest priority. Our mission is to ensure the highest level of quality and control at every stage of the production process. We are committed to full transparency and reliability in providing our partners with top-quality products.
Ilesol’s long-term goal is pharmaceutical production. The company has completed the project documentation for the production of CBD Active Pharmaceutical Ingredients (APIs). With our extensive know-how and experience, we see the future of the company as becoming one of the cannabinoid giants in the pharmaceutical sector.
We are compliant with international food safety regulations, meeting the requirements of the United Nations’ Codex Alimentarius Commission (CAC) and the Health Products Regulatory Authority (HPRA). We have implemented the Hazard Analysis Critical Control Points (HACCP) management system; HRN EN ISO 22000:2018 Food Safety Management system and GMP for food production. We hold cosmetic GMP ISO 22716 and ISO 9001 certificates. Our Quality Assurance (QA) and Quality Control (QC) processes assure vigorous implementation of certified Good Manufacturing Practices for food and cosmetic production. All of our products are third-party tested and free of pesticides, toxic solvent residues, and heavy metals. None of our products or ingredients have been tested on animals.
When it comes to our business model, quality is our highest priority. Our mission is to ensure the highest level of quality and control at every stage of the production process. We are committed to full transparency and reliability in providing our partners with top-quality products.
Ilesol’s long-term goal is pharmaceutical production. The company has completed the project documentation for the production of CBD Active Pharmaceutical Ingredients (APIs). With our extensive know-how and experience, we see the future of the company as becoming one of the cannabinoid giants in the pharmaceutical sector.